|
Q4 FY2026
As of Aug 1, 2026
|
Q3 FY2026
As of May 2, 2026
|
Q2 FY2026
As of Jan 31, 2026
|
Q1 FY2026
As of Nov 1, 2025
|
Q4 FY2025
As of Aug 2, 2025
|
Q3 FY2025
As of May 3, 2025
|
Q2 FY2025
As of Feb 1, 2025
|
Q1 FY2025
As of Nov 2, 2024
|
Q4 FY2024
As of Aug 3, 2024
|
Q3 FY2024
As of Apr 27, 2024
|
Q2 FY2024
As of Jan 27, 2024
|
Q1 FY2024
As of Oct 28, 2023
|
Q4 FY2023
As of Jul 29, 2023
|
Q3 FY2023
As of Apr 29, 2023
|
Q2 FY2023
As of Jan 28, 2023
|
Q1 FY2023
As of Oct 29, 2022
|
Q4 FY2022
As of Jul 30, 2022
|
Q3 FY2022
As of Apr 30, 2022
|
Q2 FY2022
As of Jan 29, 2022
|
Q1 FY2022
As of Oct 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Accrued compensation and benefits | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Current portion of long-term debt and finance lease liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Long-term finance lease liabilities | ||||||||||||||||||||
| Pension and other postretirement benefit obligations | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, authorized 5.0 shares; none issued or outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, authorized 100.0 shares; 64.0 shares issued and 60.3 shares outstanding at August 1, 2026; 63.1 shares issued and 60.6 shares outstanding at August 2, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock at cost | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total United Natural Foods, Inc. stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
